CD8A and neoplasm: Our findings suggest that the advantage of combinatorial ACT may result from the induction of stronger infiltration of endogenous CD8+ T cells into tumor, stronger systemic CD8+ T cell responsiveness to tumor antigen, temporal differences in melanoma cell killing, and paracrine IL-2 effects.